Defibrillators Market Industry Overview, Growth Rate and Forecast 2022-2027

1. Global Defibrillators Market Research and Forecast Report 2022- 2027 Author: Elena Anderson Marketing Manager Copyright © IMARC Service Pvt Ltd. All Rights Reserved IMARC Group © 2022 IMARC All Rights Reserved

2. Report DescriptionAbout IMARC Group International Market Analysis Research and Consulting Group is a leading adviser on management strategy and market research worldwide. We partner with clients in all regions and industry verticals to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise. IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.

3. Report Description and Highlights Report Description Global Defibrillators Market Research Report2022-2027: The latest report by IMARC Group, titled “Defibrillators Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027,” finds that the global defibrillators market size reached US$ 4.7 Billion in 2021. Defibrillators are life-saving medical devices used to deliver a therapeutic shock to the heart in case of life-threatening conditions in patients. They deliver shocks through paddles and electrode pads, which restore abnormal heart rhythms during unexpected cardiac arrest. They also depolarize the heart muscles and restore the normal electric impulse. In addition, defibrillators perform cardioversion and pacing of the heart during ventricular fibrillation, cardiac arrhythmia, and pulseless ventricular tachycardia. In recent years, defibrillators have gained immense traction during the ongoing coronavirus disease (COVID-19) pandemic to improve defibrillation delivery measures adopted by healthcare workers and decrease the delay of COVID-19 resuscitation efforts. We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report. Request for a PDF sample of this report: market/requestsample https://www.imarcgroup.com/defibrillators-

4. Report Description and Highlights Report Description Global Defibrillators Market Trends: The global defibrillators market is driven by the rising incidences of cardiac disorders, diabetes, atherosclerosis, stroke, and hypertension, especially among the rapidly growing geriatric population. Besides this, there has been an increasing adoption of implantable cardioverter defibrillators (ICDs) integrated with innovative subcutaneous and transvenous patches, which aid in improving the overall efficiency and level of comfort for the patient. In addition to this, governments across various countries are taking initiatives to focus on providing public-access defibrillators. They are also supporting awareness campaigns regarding the importance of good cardiac health, which is propelling the market growth. Furthermore, extensive investments in the healthcare sector to develop technologically advanced devices with extended longevity are also fueling the market. On account of these factors, the market is expected to grow at a CAGR of 6.94% during 2022-2027. View Report TOC, Figures and Tables: https://www.imarcgroup.com/defibrillators-market

5. Report Description and Highlights Report Description Key Market Segmentation The research report includes the following segments: Breakup by Product Type: • Implantable Defibrillators o Transvenous Implantable Cardioverter Defibrillator (T-ICDs) o Subcutaneous Implantable Cardioverter Defibrillator (S-ICDs) o Cardiac Resynchronization Therapy- Defibrillator (CRT-D) • External Defibrillators o Manual External Defibrillator o Automated External Defibrillator (AEDs) o Wearable Cardioverter Defibrillator (WCDs) Breakup by End-User: • Hospitals and Clinics • Prehospital Care Settings • Cardiac Centers • Homecare Settings • Others

6. Report Description and Highlights Report Description Breakup by Region: • North America • Asia Pacific • Europe • Latin America • Middle East and Africa Competitive Landscape: • Asahi Kasei Zoll Medical Corporation • Biotronik • Boston Scientific Corporation • Koninklijke Philips N.V. • LivaNova PLC • Medtronic Inc. • Nihon Kohden Corporation • Schiller AG • Shenzhen Mindray Bio-Medical Electronics Co.Ltd. • Stryker Corporation

7. Key Questions Answered in the Report Report Description 1. How has the global defibrillators market performed so far and how will it perform in the coming years? What are the key regional markets? What has been the impact of COVID-19 on the global defibrillators market? What is the breakup of the market based on the product type? What is the breakup of the market based on the end-user? What are the various stages in the value chain of the industry? What are the key driving factors and challenges in the industry? What is the structure of the global defibrillators market and who are the key players? What is the degree of competition in the industry? 2. 3. 4. 5. 6. 7. 8. 9.

8. Report DescriptionTable of Contents 1 Preface 2 Scope and Methodology 2.1 Objectives of the Study 2.2 Stakeholders 2.3 Data Sources 2.3.1 Primary Sources 2.3.2 Secondary Sources 2.4 Market Estimation 2.4.1 Bottom-Up Approach 2.4.2 Top-Down Approach 2.5 Forecasting Methodology 3 Executive Summary 4 Introduction 4.1 Overview 4.2 Key Industry Trends 5 Global Defibrillators Market 5.1 Market Overview 5.2 Market Performance 5.3 Impact of COVID-19 5.4 Market Forecast

9. Report DescriptionTable of Contents 6 Market Breakup by Product Type 6.1 Implantable Defibrillators 6.1.1 Market Trends 6.1.2 Major Types 6.1.2.1 Transvenous Implantable Cardioverter Defibrillator (T-ICDs) 6.1.2.2 Subcutaneous Implantable Cardioverter Defibrillator (S-ICDs) 6.1.2.3 Cardiac Resynchronization Therapy- Defibrillator (CRT-D) 6.1.3 Market Forecast 6.2 External Defibrillators 6.2.1 Market Trends 6.2.2 Major Types 6.2.2.1 Manual External Defibrillator 6.2.2.2 Automated External Defibrillator (AEDs) 6.2.2.3 Wearable Cardioverter Defibrillator (WCDs) 6.2.3 Market Forecast Click here to visit the complete table of content with list of figures and tables: https://www.imarcgroup.com/defibrillators-market/toc

10. We are the trusted business partners to the world's leading corporates, governments, and institutions Partial List of Clients A partial List of our Clients

11. We are the trusted business partners to the world's leading corporates, governments, and institutions Partial List of Clients A partial List of our Clients

12. Report Description and Highlights Report Description © 2022 IMARC All Rights Reserved This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC). Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication. IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.

13. Contact Us FOR MORE DETAILS Visit us at : https://www.imarcgroup.com Stay With Us: TELEPHONE: +1-631-791-1145 E-MAIL: sales@imarcgroup.com